Millipore Sigma Vibrant Logo

IM09L Anti-MMP-9 (Ab-1) Mouse mAb (6-6B)

This Anti-MMP-9 (Ab-1) Mouse mAb (6-6B) is validated for use in Immunoblotting, Immunoprecipitation, Neutralization Studies, Paraffin Sections for the detection of MMP-9 (Ab-1).

Anti-MMP-9 (Ab-1) Mouse mAb (6-6B) MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

Synonyms: Anti-92 kDa Gelatinase, Anti-Matrix Metalloproteinase 9, Anti-Gelatinase B, Anti-Type IV Collagenase

View Products on Sigmaaldrich.com
IM09L
View Pricing & Availability

Overview

Replacement Information

Key Specifications Table

Species ReactivityHostAntibody Type
HMMonoclonal Antibody

Pricing & Availability

Catalog Number AvailabilityPackaging Qty/Pack Price Quantity
IM09L-100UG
Retrieving availability...
—
Limited Availability Limited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      		 Plastic ampoule 100 μg
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity is a multiple of
      Maximum Quantity is
      Upon Order Completion More Information
      You Saved ()
       
      —
      Request Pricing
      		 —
      IM09L-1MG
      Retrieving availability...
      —
      Limited Availability Limited Availability
      Stocked 
      Discontinued
      Limited Quantities Available
      Available
        Remaining : Will advise
          Remaining : Will advise
          Will advise
          Contact Customer Service
          Contact Customer Service

          		 Plastic ampoule 1 mg
          Retrieving price...
          Price could not be retrieved
          Minimum Quantity is a multiple of
          Maximum Quantity is
          Upon Order Completion More Information
          You Saved ()
           
          —
          Request Pricing
          		 —
          Description
          OverviewRecognizes the ~92 kDa latent and the ~83 kDa active forms of MMP-9 under non-reducing conditions, but only the latent form under reducing conditions. Inhibits the enzymatic activity of MMP-9. For paraffin sections, use Cat. No. IM37L.
          Catalogue NumberIM09L
          Brand Family Calbiochem®
          SynonymsAnti-92 kDa Gelatinase, Anti-Matrix Metalloproteinase 9, Anti-Gelatinase B, Anti-Type IV Collagenase
          References
          ReferencesCottam, D.W. and Rees, R.C. 1993. Intl. J. of Oncol. 2, 861.
          Nakajima, M., et al. 1993. Cancer Res. 53, 5802.
          Ramos-DeSimone, et al. 1993. Hybridoma. 12, 349.
          Stetler-Stevenson, W.G., et al. 1993. FASEB. 7, 1434.
          Zucker, S., et al. 1993. Cancer Res. 53, 140.
          Woessner, J.F. 1991. FASEB. 5, 2145.
          Liotta, L.A. and Stetler-Stevenson, W.G. 1990. in Seminars in Cancer Biology, ed. M.M. Gottesman. Vol. 1; 99-106.
          Product Information
          DeclarationNot available for sale in Japan.
          FormLyophilized
          FormulationLyophilized from a volatile buffer, 100 µg BSA.
          Positive controlMMP-9 protein (Cat. Nos. PF024 or PF038)
          PreservativeNone
          Quality LevelMQ100
          Applications
          Application ReferencesImmunoprecipitation Ramos-DeSimone, N. and French, D. L. 1994. Ann. NY Acad. Sci. 732, 469. Immunoblotting, Neutralization Studies Ramos-DeSimone, N., et al. 1993. Hybridoma. 12, 349.
          Key Applications Immunoblotting (Western Blotting)
          Immunoprecipitation
          Not Paraffin Sections
          Neutralization Studies
          Application NotesImmunoblotting (2 µg/ml)
          Immunoprecipitation (see appplication references)
          Neutralization Studies (see comments and application references)
          Paraffin Sections (not recommended)
          Application CommentsInhibits MMP-9 enzymatic activity. For staining paraffin sections, use Anti-MMP-9 (626-644) (Ab-3) Mouse mAb (56-2A4) (Cat. No. IM37L). Antibody should be titrated for optimal results in individual systems.
          Biological Information
          ImmunogenMMP-9 from conditioned medium of PMA-stimulated HT-1080 human fibrosarcoma cells
          ImmunogenHuman
          Clone6-6B
          HostMouse
          IsotypeIgG₁
          Species Reactivity
          • Human
          Antibody TypeMonoclonal Antibody
          Physicochemical Information
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Ambient Temperature Only
          Toxicity Standard Handling
          Storage +2°C to +8°C
          Do not freeze Ok to freeze
          Special InstructionsStore at 4°C until reconstituted, then store in aliquots at -20°C or at 4°C with 0.1% azide. Resuspend the antibody with sterile PBS, pH 7.4, or sterile 20 mM Tris-saline, pH 7.4, to yield a final concentration of 100 µg/ml; product will be more stable if 0.1% sodium azide is included (do not add azide if antibody is to be used with viable cells). Lyophilized antibodies should be resuspended at 4°C with occasional gentle mixing for at least 2 h. Freezing of aliquots is best for long-term storage of reconstituted product; repetitive freezing and thawing should be avoided.
          Packaging Information
          Transport Information
          Supplemental Information
          Specifications
          Global Trade Item Number
          Catalog Number GTIN
          IM09L-100UG 04055977228151
          IM09L-1MG 04055977228144

          Documentation

          Anti-MMP-9 (Ab-1) Mouse mAb (6-6B) Certificates of Analysis

          TitleLot Number
          IM09L

          References

          Reference overview
          Cottam, D.W. and Rees, R.C. 1993. Intl. J. of Oncol. 2, 861.
          Nakajima, M., et al. 1993. Cancer Res. 53, 5802.
          Ramos-DeSimone, et al. 1993. Hybridoma. 12, 349.
          Stetler-Stevenson, W.G., et al. 1993. FASEB. 7, 1434.
          Zucker, S., et al. 1993. Cancer Res. 53, 140.
          Woessner, J.F. 1991. FASEB. 5, 2145.
          Liotta, L.A. and Stetler-Stevenson, W.G. 1990. in Seminars in Cancer Biology, ed. M.M. Gottesman. Vol. 1; 99-106.
          Data Sheet

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision27-August-2007 RFH
          SynonymsAnti-92 kDa Gelatinase, Anti-Matrix Metalloproteinase 9, Anti-Gelatinase B, Anti-Type IV Collagenase
          ApplicationImmunoblotting (2 µg/ml)
          Immunoprecipitation (see appplication references)
          Neutralization Studies (see comments and application references)
          Paraffin Sections (not recommended)
          DescriptionPurified mouse monoclonal antibody. Recognizes the ~92 kDa latent and the ~83 kDa active forms of human MMP-9 under non-reducing conditions, but only the latent form under reducing conditions.
          BackgroundMatrix metalloproteinases (MMP's) are a family of enzymes that are responsible for the degradation of extracellular matrix components such as collagen, laminin and proteoglycans. In addition to sequence homology, all MMP's share the following characteristics: the catalytic mechanism is dependent upon a zinc ion at the active center, they cleave one or more extracellular matrix components, they are secreted as zymogens which are activated by removal of an ~10 kDa segment from the N terminus and they are inhibited by tissue inhibitor of metalloproteinases (TIMP). These enzymes are involved in normal physiological processes such as embryogenesis and tissue remodeling and may play an important role in arthritis, periodontitis, and metastasis. MMP-9 (Gelatinase B, 92 kDa gelatinase/type IV collagenase) is secreted as a 92 kDa zymogen which is proteolytically processed to the 83 kDa active form; a 68 kDa has also been detected. MMP-9, along with its most closely related member of the MMP family, MMP-2, show substrate specificity toward type IV and V collagens, gelatin and elastin. Numerous studies have shown a correlation between collagenase expression and metastatic potential. Elevated levels of MMP-9 in plasma suggest that it may be a useful marker for the diagnosis or prognosis of cancer in general.
          HostMouse
          Immunogen speciesHuman
          ImmunogenMMP-9 from conditioned medium of PMA-stimulated HT-1080 human fibrosarcoma cells
          Clone6-6B
          IsotypeIgG₁
          Specieshuman
          Positive controlMMP-9 protein (Cat. Nos. PF024 or PF038)
          FormLyophilized
          FormulationLyophilized from a volatile buffer, 100 µg BSA.
          PreservativeNone
          CommentsInhibits MMP-9 enzymatic activity. For staining paraffin sections, use Anti-MMP-9 (626-644) (Ab-3) Mouse mAb (56-2A4) (Cat. No. IM37L). Antibody should be titrated for optimal results in individual systems.
          Storage +2°C to +8°C
          Do Not Freeze Ok to freeze
          Special InstructionsStore at 4°C until reconstituted, then store in aliquots at -20°C or at 4°C with 0.1% azide. Resuspend the antibody with sterile PBS, pH 7.4, or sterile 20 mM Tris-saline, pH 7.4, to yield a final concentration of 100 µg/ml; product will be more stable if 0.1% sodium azide is included (do not add azide if antibody is to be used with viable cells). Lyophilized antibodies should be resuspended at 4°C with occasional gentle mixing for at least 2 h. Freezing of aliquots is best for long-term storage of reconstituted product; repetitive freezing and thawing should be avoided.
          Toxicity Standard Handling
          ReferencesCottam, D.W. and Rees, R.C. 1993. Intl. J. of Oncol. 2, 861.
          Nakajima, M., et al. 1993. Cancer Res. 53, 5802.
          Ramos-DeSimone, et al. 1993. Hybridoma. 12, 349.
          Stetler-Stevenson, W.G., et al. 1993. FASEB. 7, 1434.
          Zucker, S., et al. 1993. Cancer Res. 53, 140.
          Woessner, J.F. 1991. FASEB. 5, 2145.
          Liotta, L.A. and Stetler-Stevenson, W.G. 1990. in Seminars in Cancer Biology, ed. M.M. Gottesman. Vol. 1; 99-106.
          Application referencesImmunoprecipitation Ramos-DeSimone, N. and French, D. L. 1994. Ann. NY Acad. Sci. 732, 469. Immunoblotting, Neutralization Studies Ramos-DeSimone, N., et al. 1993. Hybridoma. 12, 349.

          Related Products & Applications

          Related Products

          Catalog Number Description  
          444231 MMP-9, Monomer, Human Neutrophil Show Pricing & Availability
          444234 MMP-9-Lipocalin-TIMP-1 Complex, Human Neutrophil Show Pricing & Availability
          444252 MMP-9/MMP-13 Inhibitor I - CAS 204140-01-2 - Calbiochem Show Pricing & Availability
          QIA56 MMP-9 ELISA Kit Show Pricing & Availability

          Categories

          Life Science Research > Antibodies and Assays > Primary Antibodies